Japan's Shionogi to Buy U.S. Bioventure for 2 B. Dollars
Osaka, Oct. 6 (Jiji Press)--Major Japanese drugmaker Shionogi & Co. has said that it will acquire U.S. biopharmaceutical company IntraBio Inc. for 2 billion dollars as part of efforts to strengthen its rare disease drug business. Shionogi will buy all outstanding shares in the Austin, Texas-based company, according to an announcement Monday. Founded in 2015, IntraBio develops and commerci...
We haven't written up this one. Nippon.com News has the full story — the link below goes straight to it.
